The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for genital herpes simplex virus (HSV) among asymptomatic adults and adolescents. This recommendation forms the basis of a final recommendation ...
Feb 14, 2023
0
5
Children who receive the chickenpox (varicella) vaccine are significantly less likely to contract shingles, according to a new study led by researchers at the Kaiser Permanente Center for Health Research published today in ...
Jun 10, 2019
0
1
In a study that included approximately 15,000 pregnant women, seroprevalence of herpes simplex virus (HSV) type 2 decreased substantially between 1989 and 2010 while there was no overall decrease for HSV type 1, but a slight ...
Aug 19, 2014
0
0
(HealthDay)—A case of hepatitis E virus (HEV) infection has been reported in a kidney transplant recipient, according to a research letter published online March 1 in the Annals of Internal Medicine.
Mar 2, 2016
0
0
If you think cold and flu season is tough, trying being an infant. A new research finding published in the November 2013 issue of the Journal of Leukocyte Biology sheds new light on why newborns appear to be so prone to getting ...
Oct 31, 2013
0
0
Early in 2024, reports of a fatal case of Alaskapox were circulating in the news. A little-known virus with few cases to its name, Alaskapox virus triggers the eruption of 1 or more skin lesions on the body, among other symptoms. ...
Apr 1, 2024
0
1
More than 18 months into the pandemic, we're still hunting for effective antiviral treatments for COVID—medicines that target the coronavirus itself and stop it from developing in the body.
Nov 10, 2021
0
1
While adults make up 95 percent of those who die annually from vaccine preventable diseases, a new study from the University of Colorado School of Medicine shows their vaccination rates remain stubbornly low, representing ...
Feb 4, 2014
0
0
Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ), with the vaccine effectiveness (VE) of two doses waning a little over four years of follow-up, according to a study published online ...
Jan 9, 2024
0
1
(HealthDay)—The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), according to a news release issued by the agency today.
Apr 25, 2014
0
0
